SciSparc (SPRC) Capital Expenditures (2016 - 2020)
SciSparc (SPRC) posted Capital Expenditures of $29000.0 for Q4 2018, up 1066.67% sequentially from -$3000.0 in Q2 2018, and down 56.06% YoY from $66000.0 in Q4 2017.
SciSparc (SPRC) Capital Expenditures (2016 - 2020) Analysis & Trends
SciSparc has reported Capital Expenditures for 3 years, with the latest figure at $29000.0 in Q4 2018.
- Quarterly Capital Expenditures fell 56.06% year-over-year to $29000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $17000.0 (down 67.92% YoY) and the FY2024 annual result came in at $8000.0, changed N/A from the prior year.
- Capital Expenditures grew to $29000.0 in Q4 2018 per SPRC's latest filing, from -$3000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $66000.0 in Q4 2017 and troughed at -$15000.0 in Q3 2017.
- A 3-year average of $8625.0 and a median of -$2000.0 in 2016 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 633.33% in 2017, down 1400.0% in 2017.
- Over 3 years, Capital Expenditures stood at $9000.0 in 2016, then surged by 633.33% to $66000.0 in 2017, then tumbled by 56.06% to $29000.0 in 2018.
- According to Business Quant data, Capital Expenditures over the past three periods registered $29000.0, -$3000.0, and -$9000.0 for Q4 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 251.02 Mn |
| 10 | SciSparc | 807,202.50 | 807,202.50 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 427,000.00 |
| Jun 30, 2020 | 427,000.00 |
| Dec 31, 2018 | 29,000.00 |
| Dec 31, 2018 | 29,000.00 |
| Jun 30, 2018 | -3,000.00 |
| Jun 30, 2018 | -3,000.00 |
| Mar 31, 2018 | -9,000.00 |
| Mar 31, 2018 | -9,000.00 |
| Dec 31, 2017 | 66,000.00 |
| Dec 31, 2017 | 66,000.00 |
| Sep 30, 2017 | -15,000.00 |
| Sep 30, 2017 | -15,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Dec 31, 2016 | 9,000.00 |
| Dec 31, 2016 | 9,000.00 |
| Sep 30, 2016 | -1,000.00 |
| Sep 30, 2016 | -1,000.00 |